C-Jun N-terminal kinase (JNK) and p38 play different roles in age-related purkinje cell death in murine organotypic culture

Cerebellum

Volumn 10, Issue 2, 2011, Pages 281-290

  Repici, Mariaelena ^a,b   Wehrlé, Rosine ^a,b   Antoniou, Xanthi ^c   Borsello, Tiziana ^c   Dusart, Isabelle ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b CNRS   (France)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Cell death; JNK. p38; Organotypic culture; Purkinje cell

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL AGING; CELL CULTURE; CELL LYSATE; CELL SURVIVAL; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; TISSUE CULTURE; WESTERN BLOTTING;

AGING; ANIMALS; APOPTOSIS; ARTIFACTS; BLOTTING, WESTERN; ENZYME ACTIVATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; ORGAN CULTURE TECHNIQUES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PURKINJE CELLS; SPECIMEN HANDLING;

EID: 80051784346     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1007/s12311-010-0244-z     Document Type: Article

References (34)

1. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci. 1991;14:453-501.
2. Ghoumari AM, Wehrle R, Bernard O, Sotelo C, Dusart I. Implication of Bcl-2 and caspase-3 in age-related Purkinje cell death in murine organotypic culture: an in vitro model to study apoptosis. Eur J Neurosci. 2000;12(8):2935-49.
3. Marin-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. Microglia promote the death of developing Purkinje cells. Neuron. 2004;41(4):535-47. (Pubitemid 38253066)
4. Ghoumari AM, Wehrle R, De Zeeuw CI, Sotelo C, Dusart I. Inhibition of protein kinase C prevents Purkinje cell death but does not affect axonal regeneration. J Neurosci. 2002;22(9):3531-42. (Pubitemid 37465759)
5. Ghoumari AM, Dusart I, El-Etr M, Tronche F, Sotelo C, Schumacher M, et al. Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum. Proc Natl Acad Sci USA. 2003;100 (13):7953-8. (Pubitemid 36760076)
6. Cao J, Semenova MM, Solovyan VT, Han J, Coffey ET, Courtney MJ. Distinct requirements for p38alpha and c-Jun N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death. J Biol Chem. 2004;279(34):35903-13. (Pubitemid 39100597)
7. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron. 1999;22(4):667-76. (Pubitemid 29203491)
8. Sabapathy K, Jochum W, Hochedlinger K, Chang L, Karin M, Wagner EF. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev. 1999;89(1-2):115-24. (Pubitemid 29528280)
9. Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell Biol. 2007;19(2):142-9. (Pubitemid 46386399)
10. Borsello T, Forloni G. JNK signalling: a possible target to prevent neurodegeneration. Curr Pharm Des. 2007;13(18):1875-86. (Pubitemid 47010160)
11. Haeusgen W, Boehm R, Zhao Y, Herdegen T, Waetzig V. Specific activities of individual c-Jun N-terminal kinases in the brain. Neuroscience. 2009;161(4):951-9.
12. Bendotti C, Tortarolo M, Borsello T. Targeting stress activated protein kinases, JNK and p38, as new therapeutic approach for neurodegenerative diseases. Cent Nerv Syst Agents Med Chem. 2006;6(2):109-17. (Pubitemid 44483711)
13. Dusart I, Airaksinen MS, Sotelo C. Purkinje cell survival and axonal regeneration are age dependent: an in vitro study. J Neurosci. 1997;17(10):3710-26. (Pubitemid 27200596)
14. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods. 1991;37 (2):173-82.
15. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. Cellpermeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes. 2001;50(1):77-82. (Pubitemid 32047984)
16. Dusart I, Guenet JL, Sotelo C. Purkinje cell death: differences between developmental cell death and neurodegenerative death in mutant mice. Cerebellum. 2006;5(2):163-73. (Pubitemid 44034753)
17. Fan H, Favero M, Vogel MW. Elimination of Bax expression in mice increases cerebellar Purkinje cell numbers but not the number of granule cells. J Comp Neurol. 2001;436(1):82-91.
18. Zanjani HS, Vogel MW, Delhaye-Bouchaud N, Martinou JC, Mariani J. Increased cerebellar Purkinje cell numbers in mice overexpressing a human bcl-2 transgene. J Comp Neurol. 1996;374(3):332-41. (Pubitemid 26354796)
19. Goswami J, Martin LA, Goldowitz D, Beitz AJ, Feddersen RM. Enhanced Purkinje cell survival but compromised cerebellar function in targeted anti-apoptotic protein transgenic mice. Mol Cell Neurosci. 2005;29(2):202-21. (Pubitemid 40725611)
20. Kitao Y, Hashimoto K, Matsuyama T, Iso H, Tamatani T, Hori O, et al. ORP150/HSP12A regulates Purkinje cell survival: a role for endoplasmic reticulum stress in cerebellar development. J Neurosci. 2004;24(6):1486-96. (Pubitemid 38223001)
21. Jankowski J, Miething A, Schilling K, Baader SL. Physiological purkinje cell death is spatiotemporally organized in the developing mouse cerebellum. Cerebellum. 2009;8(3):277-90.
22. de Bilbao F, Guarin E, Nef P, Vallet P, Giannakopoulos P, Dubois-Dauphin M. Postnatal distribution of cpp 32/caspase 3 mRNA in the mouse central nervous system: an in situ hybridization study. J Comp Neurol. 1999;409(3):339-57. (Pubitemid 29262247)
23. Legos JJ, McLaughlin B, Skaper SD, Strijbos PJ, Parsons AA, Aizenman E, et al. The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. Eur J Pharmacol. 2002;447(1):37-42. (Pubitemid 34775218)
24. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, et al. Activation and involvement of p38 mitogenactivated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem. 1997;272(30):18518-21. (Pubitemid 27318185)
25. Chen RW, Qin ZH, Ren M, Kanai H, Chalecka-Franaszek E, Leeds P, et al. Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection. J Neurochem. 2003;84(3):566-75. (Pubitemid 36182255)
26. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, et al. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev. 2001;21(2):129-45. (Pubitemid 32185244)
27. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov. 2003;2(9):717-26. (Pubitemid 37361787)
28. Guan Z, Buckman SY, Pentland AP, Templeton DJ, Morrison AR. Induction of cyclooxygenase-2 by the activated MEKK1 ->SEK1/ MKK4 ->p38 mitogen-activated protein kinase pathway. J Biol Chem. 1998;273(21):12901-8. (Pubitemid 28246849)
29. Badger AM, Roshak AK, Cook MN, Newman-Tarr TM, Swift BA, Carlson K, et al. Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures. Osteoarthritis Cartilage. 2000;8(6):434-43. (Pubitemid 32000967)
30. Choi WS, Eom DS, Han BS, Kim WK, Han BH, Choi EJ, et al. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem. 2004;279 (19):20451-60. (Pubitemid 38623492)
31. Borsello T, Clarke PG, Hirt L, Vercelli A, Repici M, Schorderet DF, et al. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med. 2003;9 (9):1180-6. (Pubitemid 37173703)
32. Repici M, Centeno C, Tomasi S, Forloni G, Bonny C, Vercelli A, et al. Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation. Neuroscience. 2007;150(1):40-9. (Pubitemid 350198685)
33. Ortolano F, Colombo A, Zanier ER, Sclip A, Longhi L, Perego C, et al. c-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion. J Neuropathol Exp Neurol. 2009;68(9):964-71.
34. Repici M, Zanjani HS, Gautheron V, Borsello T, Dusart I, Mariani J. Specific JNK inhibition by D-JNKI1 protects Purkinje cells from cell death in Lurcher mutant mouse. Cerebellum. 2008;7 (4):534-8.